Stay updated on Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The recruitment status now shows 'No longer looking for participants,' indicating the study is not actively enrolling. The page revision label updated to v3.6.0, replacing the previous v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-13T00:20:33.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.5.5, was added to the Record History to indicate an update to the study record. The previous Revision: v3.5.4 was removed from the current history listing.
    Difference
    0.1%
    Check dated 2026-06-05T21:44:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The Record History shows the addition of revision v3.5.4 and the removal of revision v3.5.3, updating the page’s version history to reflect the latest revision.
    Difference
    0.1%
    Check dated 2026-05-15T12:18:37.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page’s footer software revision label was updated from v3.5.2 to v3.5.3, indicating a minor site/version change rather than a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:31:05.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added revision v3.5.2 and removed revision v3.5.0 from the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:46:51.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    On 2026-03-02, the record adds Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Outcome Measures, and Study Status, while a previous entry was deleted on 2025-09-30.
    Difference
    0.5%
    Check dated 2026-03-26T11:55:33.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.